IR BioSciences Holdings, Inc., through its subsidiary, is a biotechnology company. The Company is involved in the research and development of applications utilizing modified Substance P, a naturally occuring immunomodulator. IR's initial focus is on the continuing development of Homspera for applications for use in improving pulmonary function and stimulating the human immune system.
8777 E. Via de Ventura
Scottsdale, AZ 85258